Transgene Presents Very Promising New Immunology Data of its Next Generation Armed Oncolytic Virus at the AACR Annual Meeting in Washington, DC – Biotech 365
STRASBOURG, France–(BUSINESS WIRE)–#HBV–Regulatory News: Transgene (Paris:TNG), a biotechnology company focused on designing and developing viral-based immune-targeted therapies for the treatment of cancers and infectious diseases, announces today that it will present a poster with new and encouraging preclinical data of … Continue reading →See it on Scoop.it, via Viruses and Bioinformatics from Virology.uvic.ca
Transgene Presents Very Promising New Immunology Data of its Next Generation Armed Oncolytic Virus at the AACR Annual Meeting in Washington, DC – Biotech 365
Source: Viral Bioinformatics
